Report cover image

Stem Cell Therapy Market, by Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, and Others), by Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, and Others), and by Region (North

Publisher Coherent Market Insights
Published May 20, 2022
Length 153 Pages
SKU # CMI17213732

Description

Stem Cell Therapy Market, by Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, and Others), by Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Stem cells are divided into two major classes; pluripotent and multipotent. Pluripotent stem cells are replicating cells, which are derived from the embryo or fetal tissues. The pluripotent stem cells facilitate the development of cells and tissues in three primary germ layers such as mesoderm, ectoderm, and endoderm.
Market Dynamics
Increasing expansion of facilities by market players for stem cell therapies is expected to propel growth of the stem cell therapy market over the forecast period. For instance, in January 2021, the University of Florida, U.S. launched the Center for Regenerative Medicine that is focused on development of stem cell therapies for the treatment of damaged tissue and organ. The Centre for Regenerative Medicines is divided into two segments such as focus groups and shared services. Focus groups such as research and development activities for stem cell therapies; and the shared services segment offers technical resources related to stem cell therapies.
Furthermore, rising collaboration activities by key players are expected to drive growth of the global stem cell therapy market. For instance, in May 2021, Procella Therapeutics and Smartwise, a medtech company entered into a collaboration with AstraZeneca Pharmaceuticals. Under this collaboration, AstraZeneca utilized Procella Therapeutics’ stem cell technology for the development of stem cell therapies in cardiovascular diseases. Moreover, in April, 2019, CelluGen Biotech and FamiCord Group collaborated to develop new stem cell-based drugs and advanced medical therapies (ATMP)
Key features of the study:
This report provides in-depth analysis of the stem cell therapy market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global stem cell therapy market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as part of this study include Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., and Stemedica Cell Technologies, Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics
The global stem cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the stem cell therapy market
Detailed Segmentation:
Global Stem Cell Therapy Market, By Cell Source:
Adult Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
Others
Global Stem Cell Therapy Market, By Application:
Musculoskeletal Disorders
Wounds and Injuries
Cancer
Autoimmune disorders
Others
Global Stem Cell Therapy Market, By Region:
North America
By Cell Source:
Adult Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
Others
By Application:
Musculoskeletal Disorders
Wounds and Injuries
Cancer
Autoimmune disorders
Others
By Country:
U.S.
Canada
Latin America
By Cell Source:
Adult Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
Others
By Application:
Musculoskeletal Disorders
Wounds and Injuries
Cancer
Autoimmune disorders
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Cell Source:
Adult Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
Others
By Application:
Musculoskeletal Disorders
Wounds and Injuries
Cancer
Autoimmune disorders
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Cell Source:
Adult Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
Others
By Application:
Musculoskeletal Disorders
Wounds and Injuries
Cancer
Autoimmune disorders
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Cell Source:
Adult Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
Others
By Application:
Musculoskeletal Disorders
Wounds and Injuries
Cancer
Autoimmune disorders
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Cell Source:
Adult Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
Others
By Application:
Musculoskeletal Disorders
Wounds and Injuries
Cancer
Autoimmune disorders
Others
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Magellan*
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
Medipost Co., Ltd
Osiris Therapeutics, Inc.
Kolon TissueGene, Inc.
JCR Pharmaceuticals Co., Ltd.
Anterogen Co. Ltd.
Pharmicell Co., Inc.
Stemedica Cell Technologies, Inc.
“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

153 Pages
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Source
Market Snippet, By Therapy Type
Market Snippet, By Application
Market Snippet By, End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Key Developments
Technology Advancements
Historical Overview
Merger and Acquisition
Regulatory Scenario
PORTER’S Five Forces
PEST Analysis
4. Global Stem Cell Therapy Market, By Source, 2017 - 2028, (US$ Million)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Embryonic Stem Cells
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Adult Stem cells
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Mesenchymal Stem Cells
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Induced Pluripotent Stem Cells
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
5. Global Stem Cell Therapy Market, By Therapy Type, 2017 - 2028, (US$ Million)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Allogeneic Stem Cell Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Autologous Stem cell Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
6. Global Stem Cell Therapy Market, By Application, 2017 - 2028, (US$ Million)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Gastro-Intestine Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Central Nervous System Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Cardiovascular Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Wounds and injuries
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Eye Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Immune Therapy Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Musculoskeletal Disorders
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
7. Global Stem Cell Therapy Market, By End User, 2017 - 2028, (US$ Million)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Hospitals and Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Ambulatory Surgical centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
8. Global Stem Cell Therapy Market, By Region, 2017 - 2028, (US$ Million)
Introduction
Market Share Analysis, By Region, 2022 and 2028 (%)
Y-o-Y Growth Analysis, By Region, 2017 - 2028
Regional Trends
North America
Market Size and Forecast, By Source, 2017 - 2028, (US$ Million)
Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Source, 2017 - 2028, (US$ Million)
Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Source, 2017 - 2028, (US$ Million)
Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
Market Size and Forecast, By Application 2017 - 2028, (US$ Million)
Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Source , 2017 - 2028, (US$ Million)
Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
Market Size and Forecast, By Application, 2017 - 2028, (US$ Million
Market Size and Forecast, By End User, 2017 - 2028, (US$ Million
Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Source 2017 - 2028, (US$ Million)
Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
Market Size and Forecast, By End User, 2017 - 2028, (US$ Million
Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
North Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Source, 2017 - 2028, (US$ Million)
Market Size and Forecast, By Therapy Type ,2017 - 2028, (US$ Million)
Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
GCC Countries
Israel
Rest of Middle East
9. Competitive Landscape
Heat Map Analysis
Company Profiles
Osiris Therapeutics, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Novartis AG
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
GlaxoSmithKline Plc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
MEDIPOST Co., Ltd
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Anterogen Co., Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Pharmicell Co.Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Holostem Terapie Avanzate S.r.l
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
JCR Pharmaceuticals Co., Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
NuVasive, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
RTI Surgical, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Fibrocell Science, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Analyst Views
10. Section
References
Research Methodology
About us and Sales Contact
*Browse 23 market data tables and 19 figures on “Stem Cell Therapy Market” - Global forecast to 2028”.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us